Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

Skip to main content
Fig. 5 | Respiratory Research

Fig. 5

From: LncRNA SNHG16 promotes pulmonary fibrosis by targeting miR-455-3p to regulate the Notch2 pathway

Fig. 5

SNHG16 regulated the expression of miR-455-3p. a SNHG16 mRNA wide-type (SNHG16 WT) and the mutated-type (SNHG16 MUT) in the miR-455-3p binding sites were shown. b Luciferase activity of HEK293T cells co-transfected with miR-455-3p mimics or NC mimics and luciferase reporters containing SNHG16 WT or SNHG16 MUT transcript were determined by dual-luciferase reporter assays. c Endogenous miR-455-3p precipitated by AGO2 upon overexpression of SNHG16 was determined by RIP assay. d Relative miR-455-3p was in different groups determined by qRT-PCR. Data were expressed as mean ± SD. **P < 0.01 vs control or anti-IgG; #P < 0.05 vs TGF-β1 + Ad sh-SNHG16; ##P < 0.01 vs anti-IgG, represent statistically difference

Back to article page